Von Willebrand factor

Dec 05, 2019

Data to be Highlighted at the American Society of Hematology 2019 Annual Meeting

Sep 19, 2019

Instrumentation Laboratory Launches HemosIL® AcuStar ADAMTS13 Activity Assay In Europe And Other International Markets*

Jun 20, 2019

Versiti Blood Research Institute awarded $13M research grant

Jan 09, 2019

New England Journal of Medicine publishes positive results of the pivotal trial of Cablivi® (caplacizumab) for rare blood clotting disorder

Jun 22, 2018

A New Generation Of Coagulation Specialists Is Advancing Research With Support From CSL Behring Global Grant

Jun 21, 2018

ASH to Collaborate on Clinical Practice Guidelines on Diagnosis, Management of von Willebrand Disease

May 03, 2018

BioMatrix Specialty Pharmacy Selected As Authorized Provider Of Vonvendi

Feb 26, 2018

BloodCenter of Wisconsin presents at Thrombosis & Hemostasis Societies of North America 2018 Summit

Jun 22, 2017

Shire Announces EMA Validation of Veyvondi[TM] [Von Willebrand Factor (Recombinant)] Marketing Authorization Application for Treatment of Von Willebrand Disease